Survival differences between European and US patients with colorectal cancer: Role of stage at diagnosis and surgery

Gut

Volumn 54, Issue 2, 2005, Pages 268-273

  Ciccolallo, L ^a   Capocaccia, R ^b   Coleman, M P ^c   Berrino, F ^a   Coebergh, J W W ^d   Damhuis, R A M ^e   Faivre, J ^f   Martinez Garcia, C ^g   Moller H ^h   Ponz De Leon, M ⁱ   Launoy, G ^j   Raverdy, N ^h   Williams, E M I ^k   Gatta, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Eindhoven Cancer Registry   (Netherlands)

^e Integraal Kankercentrum Rotterdam   (Netherlands)

^f UNIVERSITÉ DE BOURGOGNE   (France)

^g ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^h Thames Cancer Registry ^*  (France)

ⁱ UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^j Calvados Digestive Cancer Registry   (France)

^k Merseyside and Cheshire Cancer Registry   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; COLORECTAL NEOPLASMS; EUROPE; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; SURVIVAL ANALYSIS; UNITED STATES;

EID: 19944433409     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.044214     Document Type: Article

References (27)

1. Gatta G, Capocaccia R, Coleman MP, et al. Toward a comparison of survival in American and European cancer patients. Cancer 2000;89:893-900.
2. Gatta G, Capocaccia R, Sant M, et al. Understanding variation in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000;47:533-8.
3. Gatta G, Ciccolallo L, Capocaccia R, the EUROCARE Working Group, et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 2003 Oct;39:2214-22.
4. Berrino F, Estève J, Coleman MP. Basic issues in estimating and comparing the survival of cancer patients. In: Berrino F, Sant M, Verdecchia A, et al, eds. Survival of cancer patients in Europe. The Eurocare Study. IARC Scient Publ No 132. Lyon: International Agency for Research on Cancer, 1995:1-14.
5. Sant M, the EUROCARE Working Group. Differences in stage and therapy for breast cancer across Europe, Int J Cancer 2001;93:894-901.
6. Sant M, Gatta G. The EUROCARE database. In: Berrino F, Sant M, Verdecchia A, et al, eds. Survival of cancer patients in Europe. The Eurocare Study. IARC Scient Publ No 132. Lyon: International Agency for Research on Cancer, 1995:15-31.
7. US Department of Health and Human Services. National Cancer Institute, Surveillance and Epidemiology End Results Program. SEER Cancer Statistics Review, 1973-1997 (dataseton CD ROM).
8. Dickman PW, Sloggetr A, Hills M, et al. Regression models for relative survival. Stat Med 2004;23:51-64.
9. World Health Organisation. International classification of diseases, 1975, 9th edn. Geneva: WHO, 1977.
10. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD, National Cancer Institute (http://seer.cancer.gov/csr/ 1973_1999/,2002).
11. Voutilainen ET, Dickman PW, Hakulinen T. SURV2: Relative survival analysis program, version 2.02a. Helsinki: Finnish Cancer Registry, 1998.
12. Micheli A, De Angelis G, Giorgi Rossi A, et al. General mortality and the survival of cancer patients in Europe. In: Berrino F, Capocaccia R, Estève J, et al, eds. Survival of cancer patients in Europe. The EUROCARE-2 study. IARC Scient Publ No 151. Lyon: International Agency for Research on Cancer, 1999:63-71.
13. StataCorp. Stata statistical software: release 7.0. College Station, TX: Stata Corporation, 2001.
14. Hermanek P, Sobin LH. TNM classification of malignant tumours, 4th edn. Geneva: UICC, 1992.
15. Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 1991;6:325-44.
16. World Health Organisation. International classification of diseases for oncology (ICD-O), 2nd edn. Geneva: WHO, 1990.
17. Breen N, Kessler L. Trends in cancer screening - United States, 1987 and 1992. MMWR Morb Mortal Wkly Rep 1995;45:57-61.
18. US Department of Health and Human Services, Healthy People 2010, Conference Edition, Section 3-12. Available from: http://www.health.gov/ healthypeople (accessed January 2000).
19. ACCP. Advisory Committee on Cancer Prevention. Recommendations on cancer screening in the European union. Eur J Cancer 2000;36:1473-8.
20. Coebergh JW, Janssen M, Louwman M, et al. Cancer incidence, care and survival in the south of the Netherlands, 1955-1999: A Report from the Eindhoven cancer registry with cross-border implications. Eindhoven: Integraal Kankercentrum Zuid, 2001.
21. Schrag D, Cramer LD, Bach PB, et al. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 2000;284:3028-35.
22. Schrag D, Panageas KS, Rieael E, et al. Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg 2002;236:583-92.
23. Mitry E, Bouvier A-M, Estève J, et al. Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg 2002;89:1557-62.
24. Berrino F, Capocaccia R, Coleman MP, et al. Survival of cancer patients in Europe. The EUROCARE-3 Study. Ann Oncol 2003;14(suppl 5).
25. Brawley OW, Freeman HP. Race and outcomes: is this the end of the beginning for minority health research? J Natl Cancer Inst 1999;91:1908-9.
26. Bullard J, Coleman MP, Robinson D, et al. Completeness of cancer registration: a new method for routine use. Br J Cancer 2000;82:1111-16.
27. Mariotto A, Capocaccia R, Verdecchia A, et al. Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes Control 2002;13:101-11.